Detalles de la búsqueda
1.
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Intern Med J
; 53(1): 119-125, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371767
2.
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Intern Med J
; 51(8): 1321-1323, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423546
3.
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Biol Blood Marrow Transplant
; 26(12): 2252-2261, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861814
4.
Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 21(11)2020 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471261
5.
Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement.
Intern Med J
; 50(6): 774-775, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32537929
6.
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Transplant Cell Ther
; 30(3): 334.e1-334.e7, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38029962
7.
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
Transplant Cell Ther
; 29(6): 383.e1-383.e10, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36934993
8.
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR.
Bone Marrow Transplant
; 57(6): 982-989, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440804
9.
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Transplant Cell Ther
; 27(12): 1022.e1-1022.e6, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34571211
10.
Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE).
BMJ Open
; 10(2): e034629, 2020 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32041862
11.
The role of a specialist bridging service. A New Zealand prospective study of 600 patients.
J Thromb Haemost
; 17(10): 1756-1761, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31215756
12.
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Bone Marrow Transplant
; 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538726
13.
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy.
Blood Adv
; 2(4): 335-346, 2018 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449224
14.
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.
Leuk Lymphoma
; 57(7): 1607-15, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26472485
Resultados
1 -
14
de 14
1
Próxima >
>>